Leukemia treatment based on U-M research gets FDA approval – The University Record

Written by

admin

in

  1. Leukemia treatment based on U-M research gets FDA approval  The University Record
  2. Karmanos Physician-Scientist Led Clinical Trial Studies, Preceding FDA-Approval of New Targeted Inhibitor for AML Patients  McLaren Health
  3. Kyowa Kirin (TSE:4151): Assessing Valuation After FDA Green Light for KOMZIFTI in AML Treatment  simplywall.st
  4. Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)  GlobeNewswire
  5. Wilson Sonsini Advises Kura Oncology on Patent and Trademark Matters Related to KOMZIFTI’s FDA Approval  Wilson Sonsini

Continue Reading

More posts